A detailed history of Ieq Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Ieq Capital, LLC holds 21,103 shares of DXCM stock, worth $1.61 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,103
Previous 20,749 1.71%
Holding current value
$1.61 Million
Previous $2.35 Million 39.88%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $22,656 - $41,085
354 Added 1.71%
21,103 $1.41 Million
Q2 2024

Aug 12, 2024

BUY
$110.31 - $140.45 $80,526 - $102,528
730 Added 3.65%
20,749 $2.35 Million
Q1 2024

May 08, 2024

BUY
$114.22 - $140.1 $162,306 - $199,082
1,421 Added 7.64%
20,019 $2.78 Million
Q4 2023

Feb 07, 2024

SELL
$75.49 - $124.16 $35,329 - $58,106
-468 Reduced 2.45%
18,598 $2.31 Million
Q3 2023

Nov 03, 2023

SELL
$86.06 - $137.93 $133,393 - $213,791
-1,550 Reduced 7.52%
19,066 $1.78 Million
Q2 2023

Aug 07, 2023

BUY
$112.47 - $130.98 $104,709 - $121,942
931 Added 4.73%
20,616 $2.65 Million
Q1 2023

May 01, 2023

SELL
$104.0 - $122.92 $96,512 - $114,069
-928 Reduced 4.5%
19,685 $2.29 Million
Q4 2022

Feb 03, 2023

BUY
$84.98 - $122.67 $175,568 - $253,436
2,066 Added 11.14%
20,613 $2.33 Million
Q3 2022

Nov 03, 2022

SELL
$76.35 - $94.18 $303,185 - $373,988
-3,971 Reduced 17.63%
18,547 $1.49 Million
Q2 2022

Jul 27, 2022

BUY
$67.99 - $132.89 $1.41 Million - $2.75 Million
20,683 Added 1127.14%
22,518 $1.68 Million
Q1 2022

Apr 26, 2022

BUY
$94.08 - $130.2 $15,711 - $21,743
167 Added 10.01%
1,835 $939,000
Q4 2021

Jan 31, 2022

BUY
$129.87 - $162.82 $29,740 - $37,285
229 Added 15.91%
1,668 $896,000
Q3 2021

Nov 09, 2021

BUY
$106.71 - $143.18 $77,258 - $103,662
724 Added 101.26%
1,439 $787,000
Q2 2021

Jul 29, 2021

BUY
$80.99 - $107.93 $57,907 - $77,169
715 New
715 $305,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.